Obj@ives. The aim of this study was to define the tenttNlal changes in the relationship lwtwn technetiumd9m tehoroxime ttwe retention and mywardtt btcad Row in a canine m&I.
tipophitic myocardiat perfusion agent, It is known to be highly extracted by the myocardium but to have a rapid ckarance rate.
,;.L;,.,L. A aide range ofmyocardial btwd Row was induced in each oxporiment by regional coronary occlusion and dipyrida. mole infusion. hlyoardial retention of technetium-99m laborox. ime was determined by in vitro tissue cowtin9 at 1, 2 or 5 mtn after injection of the tracer. Tracer retention was correlated with microsphere-determined btoal flow and the data were fitted to nontinrar functions.
Rerulu. Conxlation coefttetenfs for these functions were 0.9LO.95 and 0.95 at 1, 2, and 5 min, respectively. At 1 min after i~ectian, the relationship of technetium.l)Pm teboroxtme raten. tion to blood flow war linear over a wide flow range, becoming nonlinear at Aow rates 2.5 ndimin per g. After 5 min the retention&w relationship was linear only to 1.5 mUmin per g, above which little change in reteentton was noted. Normalined myocardial retention, expressed w a percent of Ihe relentian al 1 m"mt" wr e, was r&o catcutated. At now rates of I, L&3,4 and I.
5 m",,,h, per g, normalized retention wa IW, 169, 228, 117 and 317% at I min and 100. 171, 217, 139 and 237% at 5 min after lnjedion.
Conelusiom. At I min after injection, the relationship 01 teohnetium.99m tehoroxime mwcardtial retention to blwd Row is well maintained over a wide r&e of Row. Howver, after only 5 mtn, tracer retention underestimates flow changes at moderate rmd high Row rates. Thus, rapid acquisition protocols are nccw sary to fully exploit the potential of this proiniring new tracer in the rvatuation of myocardlat perfusion.
,J Am Colt C,,,diol1992:20:?12-9) Cardiac imagine with radiotsbeled perfusion tracers continues to be thk most important noninvzsive method for the evaluation of myocardial pmfusion. In addition to standard exercise imaging protocols, coronary flow reserve can now he assessed clinically with the use of pharmacologic vasodilation (l-5). A four-to fivefold increase in myocardial blood Row can be achieved with these agents in vascular territories with normal coronary arteries (6) (7) (8) . With this wide range of Row now achievable in the clinical setting, it becomes critical to define the relationship between a given tracer's retention in tissue and blood Row. This relationship is imponant in determinine the accuracv with which myocardial perfusion can be measured by nuclear imaging techniques (9). Three principal myocardial flow agents are now available for clinical use: thallium-ZOt. technetium-99m sestamibi and technetium-99m teboroxime. Thallium-201 is the most widely used. Its kinetics have been extensively studied (9-15). and its clinical utility and limitations are known.
Thallium.201 has a high extraction fraction by the myocardium in the ranec of 8SW (9-11). However. as flow increases. the extra&n and r&tion decrease (9-11.15). Because thallium-201 has law photou energy and a tong physical half-life that limits its suitability as an imaging agent. other Row tracers have recently been developed. Technetium99m sestamihi is one such agent. It has a lower extraction than that of thallium-201 (9.14) but a greatly prolonged tissue retention (9.14.16.17). As with thallium-201, this tracer also demonstrates a reduction in retention with increasing flow, thus limiting its ability to accurately reflect perfusion at high flow rates (9).
lcchnetium-?9m teboroxime (Cardiotec) represents the most recent Row tracer to be proposed for clinical use (18.19) . It is a neutral lipophilic boronic acid adduct of technetium dioxime (BAT01 compound that demonstrates a high level of myocardial tissue extraction (I5,20,21) with a first pass retention fraction of about 90% (21). After initial "ptake. the rCtiYity clears rapidly Emm the myocnrdium (18.20-25) at a rate proportional to blood How (21.25) However, there are limited data on the relmionshir, between tissue relention of lechnerium-99m teburoxime and myocardial blood flow. Given the tracer's stable first oar relent~on fraction over a wide Row range (21). a linear correlation between retention and Row would be expected. However. with rapid differential tissue cleararie this re\inonship may twt he maintained. A more complct,: understanding of rhese temporal changes in technerium-99a! ceboronime re'cntion it required to fully exploit its potential 8% a myocardial perfusion tracer.
Thus. ihis study was designed to define the temporal changes in the relationship between the myocardial retention of technetium-99" tehoroxime and myocwdkrlial blood Row measured by micraspheres during the 1st 5 min after tracer injection. Tissue retention measured by in vitro cowling was determined at different times after injection over a wide flow range in open chest dogs.
Methods
The study protocol was approved by the Ccmmiiiee for Animal Research at the University of Michigan and performed in accordance with the "Position of the American Heart Association on t&search Animal Use." adopted Nnvember I I, 1984 by the American Heart Association.
Exoerimental rzemwPcion. Eleven monarel doer weiehing 26 to 25 kg we;; anesthetized with in&n& sadi& wntoharbital (30 mdka hodv weight). All doas were intubated and ventilated with bxyge&nriched room air. A peripheral venous line and central venous line were inserted for intravenous access. Both femoral arteries were catheterized for continuous aortic pressure monitoring and for xterial sampling. The electrocardiogram (ECGl was also monitored continuously. A left thoracotomy was performed and the heart carefully suspended in a pericardial cradle. A left atrial catheter was inserted through the left atrial appendage for microsphere and isotope injection. The position of this catheter in the left atrium was confirmed by a left atrial pressure tracing. The proximal left circumflex coronary artmy was isolated. A Doppler Row pmhe was gently placed around it to measure relative coronary Row velocity in order to continuously monitor Row conditions during the experiment. To produce regional flow differences, the left anterior de*cen'linp coronary artery W1L ;wAnted sL"d a snare placed loosely around it for subsequent occlusion.
Tracer prepaticm. The preparation of technetium%m teboronlme by our latnnalory has been previously described (!I). BrteRy. kits conlainiag vials of teboroxime in a lyoph. i&red form were supplied by Sqmbb Diagnostics. Sodium perteehnetate technetium-99" was obtained from molybdenum-YStechnetium-59" generator? thm had been clutcd within 24 h of radiopharmaceutical preparation. All eluates were used wilhin 6 h. and mdionuclide purity. aluminum ion coment and pH were determmed before us;. Each vial was reconstirmed with 1 ml of sodium pertechnetate technetium99m containing 5 to lo mCi of radioactivity. After reeonstitution. each vial vms heated for IS min at IOVC in B b&line water i ath. The prepared mdiophammcemical was cwled 10 room temperature. and the radiochemical purity of the product W~F determined with the use of 1.3 x 1 I-cm Whatman 3 I Et chmmatogmphy strips developed in normal saline (0.5%) or normal saline/acetone (5050) solution. The &we!-aped chromatogmms were air dried and counted. The percent of free technetium-99m. reduced/hydrolyzed technetium-99" and technetium-%n teboroxime was determined. Chromatogmphic results indicated that the sum of free technetium-99" and reduced/hydrolyzed lechnetium.Wm WBE routinely <IO%, whereas the mean mdioehemieal purity was 94.5% + 2.3%.
Experimental prntoml (Fig. Il. Once blood pressure. heart rate and relative left circumt?ex eonmary anmy blwi Row were stabilized, 0.2 to 0.56 mgjkg of dipyridamole was administered intravenously over 4 min. At the end of the dipyridamole infusion the left anterior descending coronary anery was occluded by the snare. Owe Row and hemodynamics were stable (a least 5 min after occlusion). mdiolabeled microspheres and SO0 Ci of technetium-99m tebomxime were injected into the left atrium. Arterial bleed was then collected for the definition of arterial input function with the use of a Harvard pump for I min lgmup I, n = five dogs). 2 min @oup II, n = four dogs) or 5 min (group III, n = IWO dogs) after tracer injection. For animals in groups II and Ill. scadium.46~labeled micmspheres (half-lie 83.8 days) (DuPont-NEN, size 15.0 f 0.5 mm) were injected simultaneously with the tracer. In group I, microspheres were injected 1 min before the injection of technetium-99" tehoroxime. This procedure ensured that all dogs had a minimum 2.min arterial collection for the measurement of Thus. the percent maximal retention is a reliltive value, which is independent of the blood collection time.
Statistical analysis. Blood pressure, heart rate and relative coronary blood flow at baseline, after dipyridamole and before and after injection of the tracer atid microspheres were compared by analysis of variance (ANOVA) and expressed as mean value + SEW. For each dog the absolute myocardial retention of technetiumd9m teboroxima for each segment was plotted against the microsphere-determined blood Row. Each retention versus blood Row curve was fitted to a nonlinear function. Then, for each group the myocardial retention of all segments in a given group was plotted against blood Aow and also fitted to a nonlinear function. The standard error of the coefficients and the y intercept for the nonlinear function in each group were determined.
As an alternate means of assessing the retenlion-flow relation, the percent maximal retention for technetium-99m tehoroxime was plotted against the myocardial blood Row determined by the microspheres in each dog.
microsphere blood activity (see under "luirasurcme~t of myocardtal blood flow").
At the end of blood collection. the dogs were killed with a saturated solution of potassium chlorideand the heart was raddly excised. The left ventricle was cut along the short a& into slices approxiniately I cm thick. Each left venlricular slice wa, lhcn sectioned to yield samples of approximately I g. and each aample of myocardium war individually weighed. The activity in myocardial and blood samples was counted in a well counter (model 5780 Packard). Energy windows were defined for technetium-99m (II6 to 160 keVl and scandium-46 (840.1,040 keV). Blood acd lissuc samples were counted again after 72 h (I2 half-lives of techncrium99m) to correct for scandium spillover into the tcchnetium-!X9m window.
Measurement of myocardial blood flow. Myocardial blood Row (MBF, mlimin per g) was delermined by using the microsphere technique (26):
where C, is the activity in myacarc'um (countslmin per g). F, is the rate of the withdrawal pump (mlimin) and C, is the activity in collected blood (countsiminl.
Measurement of twbnetiww99m teberoxime retention. Absolute retcrdion (R) (arbitrary units, g-'I of technetium99m tebomxime was calculated as follows:
where Cbi is the blood activity corrected for di!Terent withdrawal rates.
Measurement of percent maximal technetium-!l!lm teboroxirne retention. This measurement of retention with the arterial input function as denominator assuntes that technetium99m teboroxime remains relatively unaltered while it circulates in the blood pool. Because of the very rapid clearance of technetium-99m teboroxime from the blood wol (20.21) t<4% of iniected dose oresent in the blood at i min after.iijeclion [2&, very little remains available fo; uptake beyond I min after injection. Thus, the correction for the arterial input function dppearn valid. Alterations that might reduce the availability of technetium.CNm tcboroxime for myocardial uptake would have to be very marked and occur very early aRer injection. Even with iuch changes, there would be little alteration in the blood ~001 activitv after 1 min. Nonetheless, to rule out this possibility as an &.planation for any results observed. we also measured the percent maximal retention in each dog, % ::ich is equivalent to measuring the percent maximal activity. This measurement also allowed comparison among the groups. because it was independent of each group's different blood collection times. The percent maximal retention (%R,,,) of the tracer was calculated fur each individual heart in the following nlanner: %R,,, = (R x 100)/R,,.
Results
Hemodynamte recordings. At baseline before the dipyridamole infusion, the mean systolic blood pressure and heart rate were 128 + 6 mm Hg and I50 ? 7 beatslmin, respectively. Systolic blood pressure decreased to 108 ? 7 mm He. (p < 0.0s) after diwridamole.
whereas the mean heart ra& &as I46 'I 6 beat&n (p = NS). At the time of tracer injection (at least 5 min after left anterior descending coronary artery occlusion), systolic blood pressure wes 102 + 6 mm Hg and the heart rate was 138 t 8 beats/min. After the injection of tracer and microspheres, both blood pressure and heart rate remained stable. With dipyridamolc, the relative blood flow in the circumflex artery, as measured by Doppler ultrasound, increased significantly over the baseline value. After tracer and microsphere injection, the measured circumflex artery blood Row did not change significantly.
Microsphere-determitted blood Bow. The myocardial blood flow determined by microspheres ranged from 0.01 to II.71 mllmin per g in group I. 0.01 to 7.48 mllmin per g in group II and 0.02 to 4.88 mllmin per 8 in group Ill.
Myocardial retention of technetium-99m teboroxime. There were 424 ventricular segments in group I, 308 in group II and 166 in group HI. Table I shows the nonlinear fit equations and correlation coefficients for all experiments in the three groups. The equations of the curves fitted to the overall data for each group are also shown (p a 0.001 for each group). Figure 2 shows an individual example from each group of the relationship between technetium-99m teboroxime retention and microsphere-determined blood flow. There is a progressive decline in slope and loss of linearity with time.
Percent mxilnal ntywadial retention of technetium-YYm teboroxime. The graphs in Figure 2B depict the r&&c retention cxprcsscd as a percent of the ma:ximum for each erample compared with microsphere-determired blood Row. One minute after tracer injecdon. the increase in relative retention was linear in relation to blood flow over a wide Row range. Above a Row rate of 4.5 mlirnin per g the increase was more gradual. In contrast. at 5 min after tracer injection. the data indicate a linear relation only up to a flow rate of 2.5 mllmin per g. Above this Row rate. little change in relative tracer retention was noted.
Normalized retention of teehnelium.99m iehoroxime. As a further means of comparison. a nonnalincd tissue relention was also determined (Fig. 31 . Myocardial retention valw were calculated at Row rates of 1,2.3,4 and 5 mllmin per g based on the fitted equations for individual data in each group. These calculated retention values were then cxpressed as a percent of the retention determined at a Row rate of I mllmin per g. The standard error of the fitted equation for each group was used to determine the error of the normalized retention v&es. P.: with the percent maximal retention, the normalized retention measurement is indeocndent of blood inout function.
jhc normalized retehtion values determined at the five flow rates were 100 i 7%. 169 t 11%. 228 ? 15%. 277 f 20% and 317 ? 25% at I mitt after injection, and 100 -r 12%. 171 ? 20%. 217 ? 30%. 239 ? 43% and 237 ? 56% at 5 min after injection. At I min after injection the relative increments in retention between flow rates nf I to 2.2 to 3.3 lo 4 and 4 to 5 ml/min ocr e were 69%. 59%. 4% and 40%. respectively. At 5 iin tie corresponding valueb were 71%.
46%. 22% and -2%. respectwely. The change in the increments of retention at 5 min showed a dramatic progressive reduction. In cnmgwison. at I min this change was much more gradual.
Assessment of myoeardisl clearattee from the teehnetium-!?hn tebomxime rete~~tion data. The determination of rctcneon data at three different times allowed a hmited evaluation of technetium-Y?Im teboroxime myocardial cteamnce. Figure  4 shows the retention dam at Row rates of 1. 2. 3 and 4 mVmin per g derived from the fitted curve of each group versus the three !inte prints. This graph demonstrates the differentral clearance phenomena. Al high Row rates 14 ml:min per@ tracer reiention decreases drkatically from 0.218 r 0.016 to 0.066 i 0.012 pm' between the I-and S-min mark after injection. At lower A&v rates (1 mumin per@ this reduction in retained technetium-Y9m tcboroxime is more gradual. decreasing from 0.079 + O.fC6 to O.@2g + 0.003 g-' between I and 5 min after injection.
Discussion
lnilial tissue relentian of tcchnetitun-YYm tebwoxime am! myocardisl blood Row. The principal findings of this study arc that initial technetium-YYm teboroxime tissue retention has a wrii maintained rclatioaship to myocardial blood Row over a clinically relevant flow range IO lo 4.5 mllmin per g). However, after 5 mitt the dynamic range of technetium-!Bm tebcroxime retention is markedly r:duced relative tc Row. The clinical implication ofthis ot&atron is a potential loss of sensitivity in determining regional differences in coronary Row rcscrvc. On the other hand. if retention can he measued early after injection. myocardial blood flow ca:~ be determined with a high degree of accuracy. Such early measureme", may be clinically achicvahle wilh the use of rapid data acquisilio" by mukiheaded slngk-phoron dmissio" computed tomographic (SPECT) systems. Indeed. lechiwith retention at I ml/mm peig awgncd a value of 100% in each group,. Ewor bars rep~sen, Ihe standard error of ,hc cquadon~ for each group al the respective Row raler (see Table I ). Technclism99m lehororime showed a reasonable increme", in rtxentio" for inxeasing flow r&s early afkr injection f / and 2 mink Huwever. a, 5 mi" d~ese incrcmcnla decreased progrerwely I" reladonship Lo the i"creaxe in Row. 4 I mi": fS * mi": 0 5 min. Row rates were varied among dogs by using different doses be ah;fost linearly related to Row. Indeed. the present study of the vasodilator. This technique was successful. judging by support> this hypothesis. although the re!ation between the wide range of microcphex !!etermioed Row rates iii.
tracer retenttoo and Row changed aver the tst 5 min after duced. The use of in vitro tissue counting of a large number mjectvx. of segments in each dog allowed dcrcrmination of the retenUsmg isolated heart preparations with a multi-indicator lion-flow relationship with high staistical power. ddution rechniquc, Leppo et al. (151 showed that the Tissue activity was corrected for the integral of the blood peak extract!on. capillary permeability and net extm .on activity to calculate absolute tracer retention. Accounttng (= retentton) were all higher for technetium%m teboroxime for the arterial input function appears to be appropriate than for thallium-201. They also reported a tendency fcr the because myocardial uptake of most perfusion tracers continpeak extraction to decrease with increasing blood flow. Both ues aIter their first pass through the coronar) wculatton. We tracers showed an inverse linear relation between Row and did not correct for potential metabolic alterations of t&w-peak extraction fraction and a linear relation between capiltium-99m tebomxime after injection, although such change lary flux and coronary perfusion. confirming our observacould theoretically lead to an overestimation of the true tions. However Leppo et al. (15) demonstrated a ditTosion arterial input function. However, a recent study (20) has limitatton at a relatively low t%w rate of 2.5 mlimin per g shown that at I min after in&ion only 1% of inicctcd dose lissue in the blood-wfused is&red rabbit heart. In addition of technetium-99m teboroxime is bound to red blood cells. to obvious specieshifferences. there are important methcdThis observation supports the view rhat these alterations ologic differences between their work and our present study. are not of major importance in the first minutes after
The multi-indica;or diloiion techniqce derived variables injection. In addition. the clearance of technetium-99m tebased on the continuous recovery of activity from the boroxime from the blood pool is so rapid (20.21) that the venous effluent of the isolated hean. Comparison of kinetics cotneqoeoces of later alterations in the compound are probof a vancular tracer (radiolabeled albumin) and technetiumably minimal. In support of our approach. the relative 99m tebomxime allowed the instantaneous characterization retention data. which are Independent of blood collection of tmccr extraction. In contrast. our data ax based on tracer time, and the absolute retention dam yielded similar conclw tissue retention at various times after injection in the intact sions reaardina the technetium-99m tehoroxime retentionanimal. However. the tiiewol results of the two studies blood R&v r&tionships.
suggest there is less diffusion limitation at comparable blood The eouations for the fitted carves of individual exoenflows for technetium-99m teboroximc in our model, which meats sh&n in Table 1 were almost identical in grottd 111.
may reflect maintained integrity of vascular coupling in an However. there ME some variahilitv in the eoua:ions within intact ammal. groups I and IL This variability dies not slier the overall corrlusions of this study hecuse all individual curves in group 1 were also linear over a wide flow range. The individual curve differences may be explained in part by the uifferent ranges of blood Row between errperiments. Another possible explmttlion may be lhal slight ditferences in the length ofth Icft atrial catheter and its position within the left atrium may have varied the tracer delivery time to the myocardium between experiments. This could lead to some variability in retention mea~umments early after injectho.
Techtteliom-99m teboroxime retention: comparison with previous studies. Technetium-Wm teboroxime is a neulral lipophilic BAT0 compound. The exact mechanism of its myocardial retention is not known. Given its neutral lipophilic nature, it most likely follows nonionic pathways (20). However, it is not clear whether it enters the cytosol or binds exclusivelv to the cell membrane lioid bilavcr.
Several studies have dentonstratcd high inilii! &oardiat extraction (15, 20, 21) and high capillary permeability surface area product (IS). Although we did not specifically measure these variables, our data support these previous studies by demonstrating that retention accurately reflected blood Row over a wide range early after iniection.
The clearance kinetics of technetium-99m teboroxime have been well studied. Rapid myocardial clearance has been demonstrated in cell culture models (22), animal models 120. 21, 23, 25) and human studies (l&24). The clearance rate has been shown to correlate with bled Row (21.25). and rapid disappearance ofexercise defects has beenobserved in a clinical study as well (19). We did not examine the tracer clearance directly in this study; however, we did observe a progressive reduction in the slope of the retention-flaw relation and a loss of linearity over time. Tracer tissue retention decreased more rapidly at higher flow tales (Fig.  4) . an effect consistent with the differential clearance prop erty of this tracer.
Impliitioos for lmagiog ~rotacols. Our results indicate that clinical imaeinr: orotocols must incomorate the rapid _ _.
acquisition of data after technetium-99m teboroxime iojeclion. This is in order to ?) c.zoitaiize on the excellent earlv relation of tracer reteotio.; to'blwd flow, and 2) to prevent the potentially reduced sensitivity in detecting Row reserve differences by delayed data acquisition. Given the time course of routine SPECT imaging, single-headed romographic systems may be of limited use with this agent. Normal regions with high Row after a given stress will Our data a&support previ& work from our laboratory already have had significant clearance of activi:y doting (21) that showed a stable Brst-pass retention fraction over a image acquisition aod thus may be difficult to differentiate wide range of blood flow and suggested that retention would from regiom distal to a coronary artery stenosis wbcre lhc range. An additional problem with routine SPECT imaging is the acquisition of myocardial tracer activity that is rapidly changing over time. Th!s factor could potenlially lead to imaee artifacts and thus interfere with data intemretation (27&j.
The problem is compounded when tracer'distribodon is changing at different rates (23), as would be the case when there are regional differences in flow. Becrus? of these problems, cliaical studies (l&19) to date have principally involved planar acquisition protocols. However, even planar imaging involves projections acquired al d&rent limes with potentially different tracer distribution.
On the other hand, the newer multiheaded SPECT systems may provide sufficient :emporal resolution to overcome the drawbacks of standard imaging techniques with fhis tracer. Nakajima et al. (24) used a dynamic triple-headed SPECT acquisition with 30 sets of I-mir. projections beginning at the time of injection in six patients at rest. Excluding the 1st min, which had blood pool artifact, good image quality was achieved and time-activity data acquired. According to these investigators (24), the minimal lime for a continuous rotation is 10 s with the triple-head& SPECT camera they describe. The potential for dynamic datlt acquisition with such systems may permit the absolute quantilication of blood flow by applying tracer kinetic models to time-activity data. Such a tracer kinetic model for technetium49m teboronime could utilize both the excellent early retention-flow relationship, as well as the relationship of clearance rate to blood flow (21,25).
The present study used dipyridamole to maintain stable experirkntal conditions over a prolonged period. Clinically, however, it may be advantageous to utilize the rapid decrease in myocardial blood flow that occurs after cessation of either exercise or an adenosine infusion (529). Use of a short-acting vasodilator or exercise may prolonp. the linear relation of retention to Row by d&y& thk clearance in segments with high Row rates, thus permitting longer data acquisition times with a more stable tracer distribution.
Conclusions. Techn:dum-9Ym tehoroxime demonstrates unique kinetics among available gamma.emittiog myocardial how tracers. Our study shows that a delay in awuirina !echnetium-%m teboroxime retention data may lead io significam underestimation of regional blood flow differences at moderate to high Row rat& This effect may limit the diffcrentiaGon of regions with different levels of coronary Raw reserve. In contra& early after injection there is a well maintained relationship between technetium49m teboroxime tissue retention and myocsrdial blood Row over a clinically relevant ROW range. Thus, there appears io be promise for this agent in the use of rapid acquisition pmtocols and the development of a kinetic model for the estimation of regional myocardial blood Row.
